CG
CLB icon

Cutler Group’s Core Laboratories CLB Stock Holding History

Cutler Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-230
Closed -$8.24K – 5747
2021
Q1 		$6K Buy
+230
New +$7.86K ﹤0.01% 4208
2020
Q1 		– Sell
-100
Closed -$3K – 4073
2019
Q4 		$3K Buy
+100
New +$4.49K ﹤0.01% 3246
2019
Q1 		– Sell
-400
Closed -$23K – 4103
2018
Q4 		$23K Sell
400
-100
-20% -$8.63K ﹤0.01% 2008
2018
Q3 		$57K Buy
+500
New +$56.4K ﹤0.01% 1525
2017
Q3 		– Sell
-2,745
Closed -$266K – 5934
2017
Q2 		$277K Buy
2,745
+2,010
+273% +$217K 0.01% 1041
2017
Q1 		$84K Sell
735
-3,891
-84% -$452K ﹤0.01% 1899
2016
Q4 		$555K Sell
4,626
-4,192
-48% -$464K 0.02% 643
2016
Q3 		$990K Buy
8,818
+7,023
+391% +$809K 0.04% 336
2016
Q2 		$222K Sell
1,795
-168
-9% -$20.3K 0.01% 1045
2016
Q1 		$220K Buy
1,963
+665
+51% +$69.1K 0.01% 953
2015
Q4 		$141K Buy
+1,298
New +$149K 0.01% 1467

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cutler Group's CLB Position: Q2 2021 in Review

Cutler Group sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 230 shares — an estimated $8.24K sold.

Cutler Group first reported a position in CLB in Q4 2015 and held it in 11 quarters. The position peaked at $990K in Q3 2016. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Cutler Group reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 230 Core Laboratories shares in Q2 2021, an estimated $8.24K.
  • Cutler Group first reported a position in Core Laboratories in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Core Laboratories position peaked at $990K in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.